Pure Global
NCT01952743

Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation

Concomitant Renal Denervation Therapy in Hypertensive Patients Undergoing Atrial Fibrillation Ablation - A Feasibility Study
Siva Mulpuru·ClinicalTrials.gov·procedureTerminated
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Atrial Fibrillation,Hypertension
Drug/Device/Intervention
AF ablation with Renal Denervation
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Siva Mulpuru
Funder
Mayo Clinic
Location
Rochester, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2013
End date
Oct 01, 2015
Enrollment
3 participants
Primary outcome

Atrial fibrillation (AF) Time to recurrence and Burden,Hypertension control

Summary

We propose a pilot study to assess safety and benefit of renal artery ablation at the time of
 planned atrial fibrillation ablation.

ICD-10 classifications
Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT01952743
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT01952743 through Pure Global AI's free database. This phase not specified trial is sponsored by Siva Mulpuru and is currently Terminated. The study focuses on Atrial Fibrillation,Hypertension. Target enrollment is 3 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.